Connect with us

Hi, what are you looking for?

Analgesics Market Value Size, Growth Rate, Overview, Forecast Report 2022-2027

 According to the latest report by IMARC Group, titled Analgesics Market Report: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026”, the global analgesics market reached a value of US$ 49.02 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 64.59 Billion by 2027, exhibiting at a CAGR of 4.5% during 2022-2027. Analgesics, or painkillers, are drugs that are generally prescribed to relieve pain. They are of three types: non-opioids, opioids, and compound analgesics. Commonly having no side effects, they are used for treating pain resulting from surgeries, inflammation, phantom aches, neuropathic conditions, and cancer treatments. Some of the commonly available analgesics are paracetamol, morphine and oxycodone.

We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.

Request to get the sample report:

Global Analgesics Market Trends:

The global analgesics market is primarily driven by the rising incidences of chronic disorders, including arthritis, heart disease and cancer. Coupled with the growing geriatric population across the globe, there has been a considerable rise in the sales of analgesics. In line with this, the availability of well-established healthcare facilities and easy home deliveries by e-commerce platforms are also providing an impetus to the market growth. Apart from this, continual product innovations, the manufacturing of safer opioids with improved side effects, and continual research and development (R&D) activities conducted by key players are creating a positive outlook for the market.

Explore full report with table of contents:

Global Analgesics Market 2021-2026 Analysis and Segmentation:

Competitive Landscape with Key Players:

The competitive landscape of the market has also been analyzed with some of the key players being:

  • Bayer AG
  • Novartis AG
  • GlaxoSmithKline PLC
  • Pfizer Inc
  • Johnson & Johnson
  • Reckitt Benckiser (RB)
  • Endo Pharmaceuticals
  • Bristol-Myers Squibb
  • Eli Lilly and Company
  • Sanofi.

Breakup by Type:

  • Prescription
  • Over the counter (OTC)

Breakup by Drug Class:

  • Opioids
  • Others

Breakup by Route of Administration:

  • Oral
  • Parenteral
  • Topical
  • Transdermal
  • Rectal

Breakup by Pain Type:

  • Musculoskeletal
  • Surgical and Trauma
  • Cancer
  • Neuropathic
  • Migraine
  • Obstetrical
  • Fibromyalgia
  • Pain due to Burns
  • Dental/Facial
  • Pediatric
  • Others

Breakup by Application:

  • Internal
  • External

Breakup by Region:

  • North America
  • Asia Pacific
  • Europe
  • Middle East and Africa
  • Latin America

Key highlights of the report:

  • Market Performance (2016-2021)
  • Market Outlook (2022-2027)
  • Porter’s Five Forces Analysis
  • Market Drivers and Success Factors
  • SWOT Analysis
  • Value Chain
  • Comprehensive Mapping of the Competitive Landscape

Other Report:

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us:

30 N Gould St Ste R
Sheridan, WY 82801 USA – Wyoming
Email: [email protected]
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800

Written By

You may also like:


This should be a wake-up call for global news media.  Deals don’t last forever. Nor are business models set in stone.

Tech & Science

The EU used new regulatory powers to query Meta about ad-free subscriptions to Facebook and Instagram.


Some experts are concerned that the shift from traditional healthcare services to remote consultations could be contributory to these increased deaths.


Elon Musk has launched a legal case against OpenAI, the AI firm he helped to set up in 2015, accusing its leaders of a...